Improved Diagnostic Yield in Recessive Intellectual Disability Utilizing Systematic Whole Exome Sequencing Data
Zohreh Fattahi1, Ebrahim Shokouhian1, Fatemeh Peymani1
1Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Clinical Genetics
|January 3, 2025
Summary
Reanalyzing whole exome sequencing (WES) data with updated bioinformatics tools improved the diagnosis of intellectual disability (ID) in Iranian families. This approach identified novel candidate genes and increased the diagnostic yield, highlighting WES reanalysis potential.
Area of Science:
- Genetics
- Bioinformatics
- Medical Genetics
Background:
- Whole exome sequencing (WES) is a primary genetic diagnostic tool, but limitations leave many intellectual disability (ID) cases undiagnosed.
- Reanalysis of existing WES data is crucial for improving diagnostic yield in genetic disorders.
Purpose of the Study:
- To reanalyze WES data from Iranian families with recessively inherited ID using updated bioinformatics pipelines.
- To identify novel candidate genes associated with ID and increase the diagnostic rate.
Main Methods:
- Clinical re-evaluation of 159 families with recessively inherited ID.
- Two-phase WES data reanalysis using BWA-GATK/ANNOVAR and Illumina DRAGEN/Ilyome pipelines.
- Bioinformatics functional annotation and segregation analysis for variant prioritization.
Main Results:
- The initial analysis identified causative variants in 17 families (10.6%), including six novel candidate ID genes.
- The second phase reanalysis identified variants in two additional families, increasing the total diagnostic yield to 11.9%.
- Novel candidate genes (MAZ, ACTR5, AKTIP, MIX23, SERPINB12, CDC25B) were identified and supported by functional data.
Conclusions:
- WES reanalysis with updated bioinformatics tools and phenotypic re-evaluation significantly improves diagnostic outcomes for recessively inherited ID.
- This systematic approach can uncover new gene-disease associations and reduce the need for more expensive tests like whole genome sequencing.


